These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 3281808)

  • 1. Pathogenesis of diabetic glomerulopathy: hemodynamic considerations.
    Anderson S; Brenner BM
    Diabetes Metab Rev; 1988 Mar; 4(2):163-77. PubMed ID: 3281808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current concepts of renal hemodynamics in diabetes.
    Anderson S; Vora JP
    J Diabetes Complications; 1995; 9(4):304-7. PubMed ID: 8573753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperfiltration and diabetic nephropathy: is it the beginning? Or is it the end?
    Castellino P; Shohat J; DeFronzo RA
    Semin Nephrol; 1990 May; 10(3):228-41. PubMed ID: 2190280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glomerular hemodynamic and structural alterations in experimental diabetes mellitus.
    O'Donnell MP; Kasiske BL; Keane WF
    FASEB J; 1988 May; 2(8):2339-47. PubMed ID: 3282959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of antihypertensive therapy on development and progression of diabetic glomerulopathy.
    Anderson S; Brenner BM
    Diabetes Care; 1988; 11(10):846-9. PubMed ID: 2977586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension.
    Zatz R; Dunn BR; Meyer TW; Anderson S; Rennke HG; Brenner BM
    J Clin Invest; 1986 Jun; 77(6):1925-30. PubMed ID: 3011862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated plasma atrial natriuretic peptide levels in diabetic rats. Potential mediator of hyperfiltration.
    Ortola FV; Ballermann BJ; Anderson S; Mendez RE; Brenner BM
    J Clin Invest; 1987 Sep; 80(3):670-4. PubMed ID: 2957390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of strict glycemic control on renal hemodynamic response to amino acids and renal enlargement in insulin-dependent diabetes mellitus.
    Tuttle KR; Bruton JL; Perusek MC; Lancaster JL; Kopp DT; DeFronzo RA
    N Engl J Med; 1991 Jun; 324(23):1626-32. PubMed ID: 2030719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy.
    Zatz R; Meyer TW; Rennke HG; Brenner BM
    Proc Natl Acad Sci U S A; 1985 Sep; 82(17):5963-7. PubMed ID: 3862110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glomerular abnormalities in long-term experimental diabetes. Role of hemodynamic and nonhemodynamic factors and effects of antihypertensive therapy.
    Fujihara CK; Padilha RM; Zatz R
    Diabetes; 1992 Mar; 41(3):286-93. PubMed ID: 1551488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Arterial hypertension and diabetic nephropathy].
    Chaignon M; Guedon J
    J Mal Vasc; 1992; 17(4):311-4. PubMed ID: 1494060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal and systemic hemodynamic effects of synthetic atrial natriuretic peptide in the anesthetized rat.
    Dunn BR; Ichikawa I; Pfeffer JM; Troy JL; Brenner BM
    Circ Res; 1986 Sep; 59(3):237-46. PubMed ID: 2945668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The renal hemodynamic basis of diabetic nephropathy.
    O'Bryan GT; Hostetter TH
    Semin Nephrol; 1997 Mar; 17(2):93-100. PubMed ID: 9148381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of nephron loss on glomerular hemodynamics and morphology in diabetic rats.
    O'Donnell MP; Kasiske BL; Daniels FX; Keane WF
    Diabetes; 1986 Sep; 35(9):1011-5. PubMed ID: 3743905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short and long term effects of antihypertensive therapy in the diabetic rat.
    Anderson S; Rennke HG; Garcia DL; Brenner BM
    Kidney Int; 1989 Oct; 36(4):526-36. PubMed ID: 2681929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pathophysiologic mechanisms of early changes in renal hemodynamics in diabetes mellitus].
    Komers R
    Cas Lek Cesk; 1996 Mar; 135(5):135-9. PubMed ID: 8681353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nifedipine versus fosinopril in uninephrectomized diabetic rats.
    Anderson S; Rennke HG; Brenner BM
    Kidney Int; 1992 Apr; 41(4):891-7. PubMed ID: 1387433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of angiotensin-converting enzyme inhibitors in experimental diabetes.
    Anderson S
    J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S51-4. PubMed ID: 16989065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal effects of converting enzyme inhibitors in hypertension and diabetes.
    Anderson S
    J Cardiovasc Pharmacol; 1990; 15 Suppl 3():S11-5. PubMed ID: 1691412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of glomerular capillary hypertension in experimental diabetes mellitus obviates functional and structural glomerular injury.
    Dunn BR; Zatz R; Rennke HG; Meyer TW; Anderson S; Brenner BM
    J Hypertens Suppl; 1986 Dec; 4(5):S251-4. PubMed ID: 3033178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.